Related Experiment Video
Updated: Mar 30, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Seizure outcome in patients with juvenile absence epilepsy
Ali A Asadi-Pooya1,2, Mohsen Farazdaghi3
1Neurosciences Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. aliasadipooya@yahoo.com.
Insights
This study on juvenile absence epilepsy (JAE) found no predictive factors for seizure outcomes in a small patient group. Larger multicenter studies are needed for better JAE treatment plans.
Area of Science:
- Neurology
- Epileptology
Background:
- Juvenile absence epilepsy (JAE) is a form of idiopathic generalized epilepsy (IGE).
- Predicting seizure outcomes in JAE is crucial for treatment and patient counseling.
Purpose of the Study:
- To identify seizure outcomes in patients with JAE.
- To determine factors that may predict seizure outcomes in JAE patients.
Main Methods:
- A case-control study was conducted with 33 JAE patients over 18 months.
- Patients were categorized into seizure-free and non-seizure-free groups based on the last 12 months of follow-up.
Main Results:
- 30.3% of JAE patients achieved seizure freedom.
- No specific factors were identified as predictive of seizure outcome in this cohort.
- The study highlights limitations due to small sample size and varied methodologies in existing literature.
Conclusions:
- Current evidence is insufficient to predict seizure outcomes in JAE.
- Larger, multicenter studies are necessary to identify predictive variables.
- Improved understanding will aid in individualized treatment and patient counseling for JAE.
Abstract:
The purpose of this study was to identify seizure outcome and factors potentially predictive for seizure outcome in patients with juvenile absence epilepsy (JAE). In this case-control study all patients with JAE were recruited at the outpatient epilepsy clinic at Shiraz University of Medical Sciences from 2008 till 2012. All patients had to be under the care of the epileptologist for at least 18 months. We divided the patients into two groups: patients who were seizure free in the last 12 months of their follow-up period and those who had any seizures. During the study period, 2750 patients with epilepsy were registered at our epilepsy clinic; 641 patients (23.3 %) had idiopathic generalized epilepsy (IGE). Among patients with IGE, 81 patients (12.6 %) were diagnosed as having JAE and of these, 33 patients (20 women and 13 men) were eligible to enter into the study. Ten patients (30.3 %) were seizure free in the last 12 months of their follow-up and 23 (69.6 %) patients reported at least one seizure of any type. We could not identify any factor to be associated with seizure outcome in these patients. All studies in the literature suffer from small number of patients; so does our study. Besides, they used different methodologies. A large multicenter study is required to explore the variables that predict seizure outcome in patients with juvenile absence epilepsy. This is particularly needed to provide an appropriate counselling for patients and their families and also to formulate better individualized treatment plans for the patients.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists

